MetLife Investment Management LLC lessened its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report) by 21.2% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 22,338 shares of the company’s stock after selling 6,027 shares during the quarter. MetLife Investment Management LLC’s holdings in Nu Skin Enterprises were worth $165,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently modified their holdings of NUS. The Manufacturers Life Insurance Company grew its stake in Nu Skin Enterprises by 6.0% during the second quarter. The Manufacturers Life Insurance Company now owns 19,262 shares of the company’s stock valued at $203,000 after acquiring an additional 1,096 shares in the last quarter. SummerHaven Investment Management LLC boosted its holdings in Nu Skin Enterprises by 4.7% in the 2nd quarter. SummerHaven Investment Management LLC now owns 25,778 shares of the company’s stock valued at $272,000 after purchasing an additional 1,152 shares during the period. Signaturefd LLC grew its position in shares of Nu Skin Enterprises by 72.6% during the 2nd quarter. Signaturefd LLC now owns 3,797 shares of the company’s stock valued at $40,000 after purchasing an additional 1,597 shares in the last quarter. Ensign Peak Advisors Inc increased its holdings in shares of Nu Skin Enterprises by 9.0% in the second quarter. Ensign Peak Advisors Inc now owns 19,976 shares of the company’s stock worth $211,000 after purchasing an additional 1,650 shares during the period. Finally, Inspire Advisors LLC raised its position in shares of Nu Skin Enterprises by 16.7% in the second quarter. Inspire Advisors LLC now owns 14,325 shares of the company’s stock worth $151,000 after buying an additional 2,048 shares in the last quarter. 82.84% of the stock is currently owned by institutional investors.
Nu Skin Enterprises Trading Up 3.8 %
NYSE NUS opened at $7.79 on Tuesday. The company has a quick ratio of 1.20, a current ratio of 1.93 and a debt-to-equity ratio of 0.53. The stock’s 50-day simple moving average is $6.84 and its two-hundred day simple moving average is $9.06. Nu Skin Enterprises, Inc. has a twelve month low of $5.95 and a twelve month high of $20.75. The company has a market capitalization of $386.99 million, a price-to-earnings ratio of -3.76 and a beta of 1.20.
Nu Skin Enterprises Dividend Announcement
Analysts Set New Price Targets
A number of equities analysts have weighed in on NUS shares. DA Davidson decreased their target price on Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating on the stock in a research note on Monday, August 12th. StockNews.com raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Monday, November 11th. Finally, Citigroup dropped their target price on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating for the company in a research report on Tuesday, October 22nd.
View Our Latest Analysis on Nu Skin Enterprises
About Nu Skin Enterprises
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
See Also
- Five stocks we like better than Nu Skin Enterprises
- What is a Stock Market Index and How Do You Use Them?
- How to Master Trading Discipline: Overcome Emotional Challenges
- What Are Dividends? Buy the Best Dividend Stocks
- Does China Investigation Change NVIDIA’s Outlook; Yes, No, Maybe?
- Financial Services Stocks Investing
- Is Marvell Technology Chipping Away at NVIDIA’s Market Lead?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.